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ABSTRACT: Objective—To investigate the possible benefits of in vitro fertilization (IVF) of oocytes retrieved 
during selective follicular reduction of supernumerary follicles in non-IVF cycles. Methods—Selective follic­
ular reduction of supernumerary follicles was used to prevent ovarian hyperstimulation syndrome and mul­
tiple pregnancies in gonadotropin-stimulated cycles. We analyzed the data of 13 cycles (13 women) 
retrospectively. Results—Three pregnancies occurred in these 13 cycles (23%), one after intra-uterine insem­
ination and two after timed coitus. In all cycles, oocytes were retrieved, and in 10 cycles fertilization was 
achieved (77%); in 6 cycles cryo-preservation was successful (46%) and in 3 cycles embryo transfer (ET) was 
performed (23%). All embryos were of poor quality and no pregnancies occurred after ET of frozen-thawed 
embryos. The diagnostic value of fertilization failure seems to be low, since one of the patients who failed to 
show fertilization became spontaneously pregnant afterward. Conclusion—Based on our observations, the 
beneficial effect of IVF/cryopreservation during selective follicular reduction appears questionable. Int f  Fei- 
til 41(6):506-508, 1996
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INTRODUCTION
HE USE OF GONADOTROPINS FOR THE
induction of ovulation may be complicated 
by multiple pregnancies and the ovarian 
hyperstimulation syndrome (OHSS) [1-5]. 
The risk of these complications may be reduced by 
intensive monitoring of follicular development by 
ultrasound and serum estradiol measurements. If 
too many follicles are developing or the estradiol 
level is too high, the cycle can be canceled or the 
gonadotropins can be withdrawn for several days 
("drifting" or "coasting") [6,7].
Alternative approaches are conversion of the 
cycle into in vitro fertilization (escape-IVF [8-9]) 
and ultrasound-guided selective follicular reduction 
[10,11]. During selective follicular reduction the 
two or three largest follicles remain intact and may 
result in pregnancy, and the retrieved oocytes are 
discarded.
However, the oocytes retrieved during selective 
follicular reduction can be fertilized in the IVF lab­
oratory and, after cryopreservation, embryo transfer 
(ET) of frozen-thawed embryos can be performed. 
Only one case report in the literature describes this 
combination of selective follicular reduction and 
IVF/cryopreservation [12]. There are two possible 
benefits of this procedure: fertilization can be 
tested and the pregnancy rate can be increased by 
ET of the frozen-thawed embryos. The present 
study was conducted to evaluate the possible bene­
fits of IVF/cryopreservation during selective follic­
ular reduction in non-IVF cycles.
MATERIALS AND METHODS
In our outpatient clinic controlled ovarian hyper­
stimulation is performed with human menopausal 
gonadotropin (hMG) (Humegon, Organon, Oss, the
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Netherlands) and human chorionic gonadotropin 
jhCG) (Pregnyl, Organon). Before starting  
gonadotropin treatment transvaginal ultrasonogra­
phy is done to ensure the absence of ovarian cysts. 
The initial dosage of gonadotropin preparation usu­
ally consists of 1 or 2 ampules daily (75 or 150 IU). 
Treatment is started on day 3 of the menstrual 
cycle. The next visit is planned on day 8. Follicular 
development is monitored with repeated vaginal 
ultrasonography and by frequent measurement of 
the estradiol concentration in serum with time- 
resolved fluoroimmunoassay (DELFIA; Wallac Oy, 
Turku, Finland) or enzyme-linked fluoroimmunoas­
say (ELFA, Biomerieux, Den Bosch, the Nether­
lands). Subsequently, the dose of gonadotropins may 
be increased, depending on the follicular response 
and estradiol level. If the largest follicle reaches a 
diameter of 18 mm, ovulation is induced with  
10,000 IU hCG. Injection of hCG is followed by 
insem ination (34 hours after hCG injection) or 
intercourse (30 hours after hCG injection).
The luteal phase is supported by progesterone, 
200 mg intravaginally for 12 days. If more than 
three follicles larger than 15 mm in diameter have 
developed, or the estradiol level exceeds 1,000 
pmol/L per mature follicle, the couple is informed 
about the risk of a high-grade multiple pregnancy 
and the ovarian hyperstimulation syndrome. Punc­
turing and aspirating supernumerary follicles under 
ultrasound guidance will then be considered.
We studied the results of 13 cycles in which  
selective follicular reduction was combined with 
IVF of the retrieved oocytes and cryopreservation of 
the embryos. The transvaginal aspiration of the 
supernumerary follicles took place 32-36 hours 
after hCG injection, leaving the two or three largest 
follicles in situ. Aspiration was performed after the 
administration of analgesic or sedative medication. 
The number of oocytes was counted under a stere- 
omicroscope. Each oocyte was inseminated in a tis­
sue culture disk with approximately 100,000 motile 
spermatozoa. If fertilization  was achieved, an 
attempt was made to cryopreserve the embryos. 
OHSS was classified according to Golan et al [13]. 
Results are expressed as mean ± standard deviation.
RESULTS
Thirteen cycles in 13 women were analyzed. Mean 
duration of infertility was 2.4 ± 1.4 years, the aver­
age age of the patients was 31.2 ± 4.4 years. The 
cause of infertility was andrologic (3 couples) or 
anovulation (10 couples). The number of ampules at 
start was 1.2 ± 0,5 and the total number of ampules 
per cycle was 24.5 ± 7.5. The maximum serum estra­
diol level was 7,520 ± 3,920 (pmol/L), and the num­
ber of follicles >15 mm was 8.9 ± 3.3. In 3 cycles, 
intra-uterine insemination (IUI) was performed, and 
in 10 cycles timed coitus was advised. All 13 cycles 
were ovulatory, and none of the cycles had to be 
canceled on account of premature ovulation.
Three of the 13 treatment cycles (23%) resulted 
in ongoing singleton pregnancies (two after timed 
coitus and one after IUI). Oocytes were retrieved in 
all cycles and the mean number of oocytes per 
cycle was 10.5 ± 7.4 (range 2-26, n = 13). Fertiliza­
tion was achieved in 10 of the 13 cycles (77%) and 
in 70 of the 136 oocytes (51%). The mean number 
of fertilized oocytes per cycle was 5.4 ± 4.6 (range 
0-15, n = 13). One of the three couples that did not 
show fertilization achieved pregnancy sponta­
neously 2 years after the procedure.
In 4 of the 10 cycles with fertilization, cryo­
preservation was not successful because of bad mor­
phological quality of the embryos. In 6 cycles 
(46%), cryopreservation was successful (46/70 
embryos; 66%). The mean number of cryopreserved 
embryos per cycle was 3.5 ± 5.0 (range 0-15, n « 13). 
In three of those six couples ET was carried out. 
The number of transferred embryos was 2 (1 good 
and 1 bad quality), 3 (2 moderate and 1 bad quality), 
and 4 (2 moderate and 2 bad quality). No pregnan­
cies occurred after ET of these thawed embryos. In 
two of the six couples, ET was not performed 
because pregnancy was achieved in the cycle during 
which the aspiration of supernumerary follicles was 
performed, and in one of the six couples, because of 
the very bad quality of the thawed embryos.
None of the treatment cycles were complicated 
by any moderate or severe forms of OHSS. In five 
women (38%) mild signs of OHSS were observed 
including abdominal distention and discomfort. 
Two of these patients were pregnant. Complica­
tions of follicle aspiration, such as pelvic infections 
or abdominal bleeding, did not occur.
DISCUSSION
The main goal of this study was to evaluate the 
possible benefits of IVF of the oocytes retrieved
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during selective follicular reduction in non-IVF 
cycles. This procedure, resulting in cryopreserva­
tion of embryos, might increase the pregnancy rate 
of the whole treatment. Secondly, IVF of retrieved 
oocytes during aspiration of supernumerary folli­
cles can be used as diagnostic test whether or not 
fertilization in a couple can be achieved.
The value of IVF aspiration of supernumerary 
follicles seems to be arguable. We found that in 
only 38% of the cycles could embryos be cryopre- 
served, and in only 23% of the cycles was ET 
deemed worth performing. The embryos were 
mostly of morphologically bad quality, and no preg­
nancies occurred after ET of thawed embryos. 
Although the numbers are small, this observation 
is in agreement with the literature, since no preg­
nancies have been described with frozen-thawed 
embryos after selective follicular reduction [12].
In addition, the predictive value of fertilization 
failure is not great: in this study, one of the three 
couples whose retrieved oocytes were not fertiliz- 
able achieved pregnancy spontaneously 2 years 
after the procedure.
A good explanation for the probably low additive 
value of IVF and cryo-ET after selective aspiration 
of supernumerary follicles remains difficult. Possi­
bly, the maturity of the oocytes is not optimal, 
because of the relatively small diameter of the aspi­
rated follicles. The two or three largest follicles are 
left in situ, and may contain the best oocytes. Our 
data support the concept that selective follicular 
reduction in non-IVF cycles is a good alternative or 
supplement to such previously described methods 
as cancellation, "drifting," "coasting" [6-7] or 
escape-IVF [8-9]. The pregnancy rate is good, and 
the risk of m ultiple pregnancies and OHSS is 
reduced [11].
In conclusion, our data and the data in the litera­
ture show that selective follicular reduction is an 
effective method for reducing the frequency of 
OHSS and m ultiple pregnancies after ovarian 
hyperstimulation, without compromising the preg­
nancy rate. Furthermore, our data show that 
the beneficial effect of IVF/cryopreservation during 
selective follicular reduction is questionable. 
We believe this procedure should not be practiced 
until the opposite has been proved in randomized 
studies.
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